Saturday, May 25, 2013 Last update: 8:34 AM
Company Tech News as it Breaks
Quidel
Website:
http://www.quidel.comQDEL
News articles for Quidel:
Wednesday, May 8, 2013
- Quidel to Present at Bank of America Merrill Lynch 2013 Health Care ConferenceSAN DIEGO, CA -- (Marketwired) -- 05/08/13 -- Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cell-based virology assays and molecular diagnostic systems, announced today that it will present at the Bank of America Merrill Lynch Health Care Conference to be held at the Encore ... read more
Wednesday, April 10, 2013
- Quidel to Hold First Quarter 2013 Financial Results Conference Call on April 23, 2013SAN DIEGO, CA -- (Marketwired) -- 04/10/13 -- Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic solutions, will release first quarter 2013 financial results after market close on Tuesday, April 23, 2013. Following the release of results, Douglas Bryant, president ... read more
Monday, February 25, 2013
- Quidel to Host 2013 Analyst and Investor Day in BostonSAN DIEGO, CA -- (Marketwire) -- 02/25/13 -- Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions, today announced that it will host its 2013 Quidel Analyst and Investor Day at the Boston Marriott Long Wharf hotel in Boston, Massachusetts on Thursday, March 7, 2013. Quidel's management ... read moreQuidel to Present at Cowen 33rd Annual Health Care ConferenceSAN DIEGO, CA -- (Marketwire) -- 02/25/13 -- Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions and cellular-based virology assays, announced today that it will present at the Cowen and Company 33rd Annual Health Care Conference to be held at the Boston Marriott Copley Place ... read more
Thursday, January 31, 2013
- Quidel to Hold Fourth Quarter and Full Year 2012 Financial Results Conference Call on February 12, 2013SAN DIEGO, CA -- (Marketwire) -- 01/31/13 -- Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions and cellular-based virology assays, will release fourth quarter and full year 2012 financial results after market close on Tuesday, February 12, 2013. Following the release of results, Douglas Bryant, president ... read more
Wednesday, January 2, 2013
- Quidel to Present at 31st Annual J.P. Morgan Healthcare ConferenceSAN DIEGO, CA -- (Marketwire) -- 01/02/13 -- Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions and cellular-based virology assays, announced today that it will present at the 31st Annual J.P. Morgan Healthcare Conference to be held at The Westin St. Francis hotel in San ... read more
Tuesday, November 20, 2012
- Quidel to Present at 24th Annual Piper Jaffray Healthcare ConferenceSAN DIEGO, CA -- (Marketwire) -- 11/20/12 -- Quidel Corporation (NASDAQ: QDEL), a leading provider of diagnostic testing solutions and cellular-based virology assays, announced today that it will present at the 24th Annual Piper Jaffray Healthcare Conference to be held at The New York Palace hotel in New York, ... read more
Wednesday, November 7, 2012
- Quidel to Present at Credit Suisse 2012 Healthcare ConferenceSAN DIEGO, CA -- (Marketwire) -- 11/07/12 -- Quidel Corporation (NASDAQ: QDEL), a leading provider of diagnostic testing solutions and cellular-based virology assays, announced today that it will present at the Credit Suisse 2012 Healthcare Conference to be held at the Arizona Biltmore hotel in Phoenix, Arizona on Wednesday, ... read more
Tuesday, October 9, 2012
- Quidel to Hold Third Quarter 2012 Financial Results Conference Call on October 23, 2012SAN DIEGO, CA -- (Marketwire) -- 10/09/12 -- Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions and cellular-based virology assays, will release third quarter 2012 financial results after market close on Tuesday, October 23, 2012. Following the release of results, Douglas Bryant, president and chief executive ... read more
Friday, August 10, 2012
- Quidel Secures New $140 Million Credit FacilitySAN DIEGO, CA -- (Marketwire) -- 08/10/12 -- Quidel Corporation (NASDAQ: QDEL), a leading provider of diagnostic testing solutions and cellular-based virology assays, announced today that it entered into an amended and restated $140 million, five-year senior secured credit facility with a group of banks, led by Bank of ... read more
Tuesday, July 31, 2012
- Quidel to Present at Canaccord Genuity 32nd Annual Growth ConferenceSAN DIEGO, CA -- (Marketwire) -- 07/31/12 -- Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions and cellular-based virology assays, announced today that it will present at the Canaccord Genuity 32nd Annual Growth Conference to be held at the InterContinental Boston hotel in Boston, Massachusetts ... read more
Tuesday, July 10, 2012
- Quidel to Hold Second Quarter 2012 Financial Results Conference Call on July 25, 2012SAN DIEGO, CA -- (Marketwire) -- 07/10/12 -- Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions and cellular-based virology assays, will release second quarter 2012 financial results after market close on Wednesday, July 25, 2012. Following the release of results, Douglas Bryant, president and chief ... read more
Thursday, May 31, 2012
- Quidel to Present at Upcoming ConferencesSAN DIEGO, CA -- (Marketwire) -- 05/31/12 -- Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions and cellular-based virology assays, announced today that it will present at the following upcoming conferences: The Goldman Sachs 33rd Annual Global Healthcare Conference at the Terranea Resort in Rancho ... read more
Friday, April 13, 2012
- Quidel to Hold First Quarter 2012 Financial Results Conference Call on April 25, 2012SAN DIEGO, CA -- (Marketwire) -- 04/13/12 -- Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions and cellular-based virology assays, will release first quarter 2012 financial results after market close on Wednesday, April 25, 2012. Following the release of results, Douglas Bryant, president and chief ... read more
Monday, April 2, 2012
- Quidel Receives CE Mark for Its Direct Specimen Rapid PCR Test for Toxigenic Clostridium DifficileSAN DIEGO, CA -- (Marketwire) -- 04/02/12 -- Quidel Corporation (NASDAQ: QDEL) announced today that it received CE mark for the Quidel Molecular™ Direct C. difficile Tox A/B assay for the detection of toxigenic Clostridium difficile bacterial DNA. C. difficile infection is frequently associated with antibiotic therapy and ... read more
Tuesday, March 27, 2012
- Quidel Receives CE Mark for Its AmpliVue(TM) Hand-Held Molecular Diagnostic Test for Clostridium DifficileSAN DIEGO, CA -- (Marketwire) -- 03/27/12 -- Quidel Corporation (NASDAQ: QDEL), announced today that it received CE mark for the AmpliVue C. difficile assay, its non-instrumented molecular test for the detection of toxigenic Clostridium difficile bacterial DNA. Detection of the pathogen is achieved using a hand-held fully ... read more
Thursday, March 22, 2012
- Quidel Receives FDA Clearance for Its Quidel Molecular(TM) Influenza A+B Assay for Use With Cepheid SmartCycler(R)SAN DIEGO, CA -- (Marketwire) -- 03/22/12 -- Quidel Corporation (NASDAQ: QDEL), a leading provider of diagnostic testing solutions, announced today that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its Quidel Molecular™ Influenza A+B Assay for the detection of influenza ... read more
Monday, March 12, 2012
- Quidel Receives CE Mark for Its Molecular Diagnostic Test for Respiratory Syncytial Virus (RSV) and Human Metapneumovirus (hMPV)SAN DIEGO, CA -- (Marketwire) -- 03/12/12 -- Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions and cell-based virology assays, announced today that it has received the CE Mark for the Quidel Molecular™ RSV + hMPV assay for the detection of respiratory syncytial virus ... read more
Thursday, February 2, 2012
- Quidel to Hold Fourth Quarter and Full Year 2011 Financial Results Conference Call on February 29, 2012SAN DIEGO, CA -- (Marketwire) -- 02/02/12 -- Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions and cellular-based virology assays, will release fourth quarter and full year 2011 financial results after market close on Wednesday, February 29, 2012. Following the release of results, Douglas Bryant, ... read more
Wednesday, January 4, 2012
- Quidel to Present at 30th Annual J.P. Morgan Health Care ConferenceSAN DIEGO, CA -- (Marketwire) -- 01/04/12 -- Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions and cellular-based virology assays, announced today that it will present at the 30th Annual J.P. Morgan Health Care Conference to be held at The Westin St. Francis hotel ... read more